Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jessica Tozour is active.

Publication


Featured researches published by Jessica Tozour.


PLOS Genetics | 2014

Mosaic Epigenetic Dysregulation of Ectodermal Cells in Autism Spectrum Disorder

Esther R. Berko; Masako Suzuki; Faygel Beren; Christophe Lemetre; Christine M. Alaimo; R. Brent Calder; Karen Ballaban-Gil; Batya Gounder; Kaylee Kampf; Jill Kirschen; Shahina Maqbool; Zeineen Momin; David M. Reynolds; Natalie Russo; Lisa Shulman; Edyta Stasiek; Jessica Tozour; Maria Valicenti-McDermott; Shenglong Wang; Brett S. Abrahams; Joseph Hargitai; Dov Inbar; Zhengdong D. Zhang; Joseph D. Buxbaum; Sophie Molholm; John J. Foxe; Robert W. Marion; Adam Auton; John M. Greally

DNA mutational events are increasingly being identified in autism spectrum disorder (ASD), but the potential additional role of dysregulation of the epigenome in the pathogenesis of the condition remains unclear. The epigenome is of interest as a possible mediator of environmental effects during development, encoding a cellular memory reflected by altered function of progeny cells. Advanced maternal age (AMA) is associated with an increased risk of having a child with ASD for reasons that are not understood. To explore whether AMA involves covert aneuploidy or epigenetic dysregulation leading to ASD in the offspring, we tested a homogeneous ectodermal cell type from 47 individuals with ASD compared with 48 typically developing (TD) controls born to mothers of ≥35 years, using a quantitative genome-wide DNA methylation assay. We show that DNA methylation patterns are dysregulated in ectodermal cells in these individuals, having accounted for confounding effects due to subject age, sex and ancestral haplotype. We did not find mosaic aneuploidy or copy number variability to occur at differentially-methylated regions in these subjects. Of note, the loci with distinctive DNA methylation were found at genes expressed in the brain and encoding protein products significantly enriched for interactions with those produced by known ASD-causing genes, representing a perturbation by epigenomic dysregulation of the same networks compromised by DNA mutational mechanisms. The results indicate the presence of a mosaic subpopulation of epigenetically-dysregulated, ectodermally-derived cells in subjects with ASD. The epigenetic dysregulation observed in these ASD subjects born to older mothers may be associated with aging parental gametes, environmental influences during embryogenesis or could be the consequence of mutations of the chromatin regulatory genes increasingly implicated in ASD. The results indicate that epigenetic dysregulatory mechanisms may complement and interact with DNA mutations in the pathogenesis of the disorder.


Nature Communications | 2014

Sexual dimorphism in epigenomic responses of stem cells to extreme fetal growth.

Fabien Delahaye; N. Ari Wijetunga; Hye Heo; Jessica Tozour; Yong Mei Zhao; John M. Greally; Francine Einstein

Extreme fetal growth is associated with increased susceptibility to a range of adult diseases through an unknown mechanism of cellular memory. We tested whether heritable epigenetic processes in long-lived CD34+ hematopoietic stem/progenitor cells (HSPCs) showed evidence for re-programming associated with the extremes of fetal growth. Here we show that both fetal growth restriction and over-growth are associated with global shifts towards DNA hypermethylation, targeting cis-regulatory elements in proximity to genes involved in glucose homeostasis and stem cell function. We find a sexually dimorphic response; intrauterine growth restriction (IUGR) is associated with substantially greater epigenetic dysregulation in males, whereas large for gestational age (LGA) growth predominantly affects females. The findings are consistent with extreme fetal growth interacting with variable fetal susceptibility to influence cellular aging and metabolic characteristics through epigenetic mechanisms, potentially generating biomarkers that could identify infants at higher risk for chronic disease later in life.


Oncogene | 2017

A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets

N A Wijetunga; Marien Pascual; Jessica Tozour; Fabien Delahaye; M Alani; M Adeyeye; A W Wolkoff; Amit Verma; John M. Greally

The predisposition of patients with Hepatitis C virus (HCV) infection to hepatocellular carcinoma (HCC) involves components of viral infection, inflammation and time. The development of multifocal, genetically distinct tumours is suggestive of a field defect affecting the entire liver. The molecular susceptibility mediating such a field defect is not understood. One potential mediator of long-term cellular reprogramming is heritable (epigenetic) regulation of transcription, exemplified by DNA methylation. We studied epigenetic and transcriptional changes in HCV-infected livers in comparison with control, uninfected livers and HCC, allowing us to identify pre-neoplastic epigenetic and transcriptional events. We find the HCV-infected liver to have a pattern of acquisition of DNA methylation targeted to candidate enhancers active in liver cells, enriched for the binding sites of the FOXA1, FOXA2 and HNF4A transcription factors. These enhancers can be subdivided into those proximal to genes implicated in liver cancer or to genes involved in stem cell development, the latter distinguished by increased CG dinucleotide density and polycomb-mediated repression, manifested by the additional acquisition of histone H3 lysine 27 trimethylation (H3K27me3). Transcriptional studies on our samples showed that the increased DNA methylation at enhancers was associated with decreased local gene expression, results validated in independent samples from The Cancer Genome Atlas. Pharmacological depletion of H3K27me3 using the EZH2 inhibitor GSK343 in HepG2 cells suppressed cell growth and also revealed that local acquired DNA methylation was not dependent upon the presence of polycomb-mediated repression. The results support a model of HCV infection influencing the binding of transcription factors to cognate sites in the genome, with consequent local acquisition of DNA methylation, and the added repressive influence of polycomb at a subset of CG-dense cis-regulatory sequences. These epigenetic events occur before neoplastic transformation, resulting in what may be a pharmacologically reversible epigenetic field defect in HCV-infected liver.


Aging Cell | 2016

Advanced aging phenotype is revealed by epigenetic modifications in rat liver after in utero malnutrition

Hye Heo; Jessica Tozour; Fabien Delahaye; Yongmei Zhao; Lingguang Cui; Nir Barzilai; Francine Einstein

Adverse environmental exposures of mothers during fetal period predispose offspring to a range of age‐related diseases earlier in life. Here, we set to determine whether a deregulated epigenetic pattern is similar in young animals whose mothers’ nutrition was modulated during fetal growth to that acquired during normal aging in animals. Using a rodent model of maternal undernutrition (UN) or overnutrition (ON), we examined cytosine methylation profiles of liver from young female offspring and compared them to age‐matched young controls and aged (20‐month‐old) animals. HELP‐tagging, a genomewide restriction enzyme and sequencing assay demonstrates that fetal exposure to two different maternal diets is associated with nonrandom dysregulation of methylation levels with profiles similar to those seen in normal aging animals and occur in regions mapped to genes relevant to metabolic diseases and aging. Functional consequences were assessed by gene expression at 9 weeks old with more significant changes at 6 months of age. Early developmental exposures to unfavorable maternal diets result in altered methylation profiles and transcriptional dysregulation in Prkcb, Pc, Ncor2, and Smad3 that is also seen with normal aging. These Notch pathway and lipogenesis genes may be useful for prediction of later susceptibility to chronic disease.


Oncotarget | 2016

A polycomb-mediated epigenetic field defect precedes invasive cervical carcinoma.

Neil Ari Wijetunga; Miriam Ben-Dayan; Jessica Tozour; Robert D. Burk; Nicolas F. Schlecht; Mark H. Einstein; John M. Greally

Human papillomavirus (HPV)-associated cervical carcinoma is preceded by stages of cervical intra-epithelial neoplasia (CIN) that can variably progress to malignancy. Understanding the different molecular processes involved in the progression of pre-malignant CIN is critical to the development of improved predictive and interventional capabilities. We tested the role of regulators of transcription in both the development and the progression of HPV-associated CIN, performing the most comprehensive genomic survey to date of DNA methylation in HPV-associated cervical neoplasia, testing ~2 million loci throughout the human genome in biopsies from 78 HPV+ women, identifying changes starting in early CIN and maintained through carcinogenesis. We identified loci at which DNA methylation is consistently altered, beginning early in the course of neoplastic disease and progressing with disease advancement. While the loss of DNA methylation occurs mostly at intergenic regions, acquisition of DNA methylation is at sites involved in transcriptional regulation, with strong enrichment for targets of polycomb repression. Using an independent cohort from The Cancer Genome Atlas, we validated the loci with increased DNA methylation and found that these regulatory changes were associated with locally decreased gene expression. Secondary validation using immunohistochemistry showed that the progression of neoplasia was associated with increasing polycomb protein expression specifically in the cervical epithelium. We find that perturbations of genomic regulatory processes occur early and persist in cervical carcinoma. The results indicate a polycomb-mediated epigenetic field defect in cervical neoplasia that may represent a target for early, topical interventions using polycomb inhibitors.


Stem Cells and Development | 2018

Intrauterine hyperglycemia is associated with an impaired postnatal response to oxidative damage.

Jessica Tozour; Fabien Delahaye; Masako Suzuki; Aaron Praiss; Yongmei Zhao; Lingguang Cui; Hye Heo; John M. Greally; Francine Hughes

Hyperglycemia and other adverse exposures early in life that reprogram stem cells may lead to long-lasting phenotypic influences over the lifetime of an individual. Hyperglycemia and oxidative stress cause DNA damage when they exceed the protective capabilities of the cell, in turn affecting cellular function. DNA damage in response to hyperglycemia and oxidative stress was studied in human umbilical cord mesenchymal stem cells (hUC-MSCs) from large-for-gestational-age (LGA) infants of mothers with gestational diabetes mellitus (LGA-GDM) and control subjects. We tested the response of these cells to hyperglycemia and oxidative stress, measuring reactive oxygen species (ROS) levels and antioxidant enzyme activities. We find that hUC-MSCs from LGA-GDM infants have increased DNA damage when exposed to oxidative stress. With the addition of hyperglycemic conditions, these cells have an increase in ROS and a decrease in antioxidant glutathione peroxidase (GPx) activity, indicating a mechanism for the increased ROS and DNA damage. This study demonstrates that a memory of in utero hyperglycemia, mediated through downregulation of GPx activity, leads to an increased susceptibility to oxidative stress. The alteration of GPx function in self-renewing stem cells, can mediate the effect of intrauterine hyperglycemia to be propagated into adulthood and contribute to disease susceptibility.


American Journal of Obstetrics and Gynecology | 2016

228: Fetal over nutrition enhances mesenchymal stem cell response to oxidative stress

Jessica Tozour; Fabien Delahaye; Yongmei Zhao; Lingguang Cui; Hye Heo; Francine Einstein


American Journal of Obstetrics and Gynecology | 2016

230: Maternal diet-induced changes in DNA methylation precede gene expression changes in liver

Hye Heo; Jessica Tozour; Fabien Delahaye; Yongmei Zhao; Lingguang Cui; Francine Einstein


American Journal of Obstetrics and Gynecology | 2016

232: Excessive fetal growth associated with premature aging phenotype of hematopoietic progenitor cells

Fabien Delahaye; Jessica Tozour; Yongmei Zhao; Hye Heo; Francine Einstein


American Journal of Obstetrics and Gynecology | 2015

162: Urinary nephrin is an early biomarker for chronic kidney disease in maternal caloric restricted rats

Hye Heo; Natalie Uy; Fabien Delahaye; Jessica Tozour; Howard Slomko; Yongmei Zhao; Kimberly Reidy; Francine Einstein

Collaboration


Dive into the Jessica Tozour's collaboration.

Top Co-Authors

Avatar

Fabien Delahaye

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Hye Heo

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Francine Einstein

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Yongmei Zhao

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

John M. Greally

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Lingguang Cui

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Nir Barzilai

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Aaron Praiss

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Adam Auton

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Amit Verma

Albert Einstein College of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge